Full trading conditions >>
|Product Type: Stock CFD|
|Sector: Health Care||Industry: Pharmaceuticals, Biotechnology & Life Sciences|
|Country: Australia||Currency: AUD|
|Trading Hours: 23:01-05.:10 GMT||Measurement Unit: Shares|
Based in Parkville, Melbourne, Victoria, CSL Limited is a biotechnology company that develops and manufactures blood plasma derivatives, vaccines, antivenom, and cell culture reagents. In 2016, the company had a net income of USD$1,769 million and a revenue of USD$6.923 billion. CSL created the first vaccine for the Swine Flu crisis in 2009.